Published Paper Details:

Brain abscess / intracranial abscess is a central nervous system disease caused by the infection from bacterial viral ,fungal etc. sources leading to a pus filled capsule inside the brain. It is a complicated and life threatening disease since currently there are no widely accepted neurosurgical management guidelines. Brain abscess has a high morbidity and mortality rate thus, the disease is currently a major public health problem. Majority of the pathogens are bacterial in nature eg -streptococcus , staphylococcus etc. In this study ,we have established some therapeutics against brain abscess using in silico network biology approaches. The selection of therapeutics and antibiotics depends on the microorganisms isolated from blood or CSF and their ability to cross the natural barriers of brain (BBB). The construction of network consisting genes associated with brain abscess were collected from different databases like malacard,genecard, and thorough literature study using cytoscape. The network consists of nodes representing genes and interactions between them. We identified two hub genes (STAT3 and IL6)from the network having highest degree and satisfying various parameters like MCC,MNC,stress etc. .We analyzed the role of target gene in brain abscess. A virtual library consisting of various antimicrobial compounds as ligands was made .Molecular Docking using auto dock vina1.5.6 version was done and through this study we found out promising therapeutics against brain abscess .In conclusion we found out the role of STAT3 and IL6 gene in brain abscess and established therapeutics against the causative agents . The docking simulations revealed several promising candidates with high binding affinity and favorable interaction patterns with the target proteins implicated in brain abscess pathophysiology. Furthermore, structural analysis of the ligand-receptor complexes provided insights into the molecular mechanisms of action and potential modes of inhibition for the identified compounds. Our findings highlight the potential of computational docking techniques in accelerating the discovery and development of novel therapeutics for brain abscess treatment. Future experimental validation of the identified lead compounds is warranted to confirm their efficacy, selectivity, and safety profiles in preclinical and clinical settings. Overall, this computational study contributes to the ongoing efforts to combat brain abscesses and improve patient outcomes through the rational design of targeted pharmacological interventions.